4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-003009
Options or other derivatives
- Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Moretti August J · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-10 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +50,000 | 50,000 | D |
Loading xslF345X03/doc1.xml…